We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sanofi | EU:SAN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.64 | -0.71% | 89.52 | 89.50 | 90.00 | 90.41 | 89.44 | 90.16 | 911,282 | 16:40:00 |
From May 2019 to May 2024
By Inti Landauro
PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Wednesday said it teamed up with closely held Myokardia to develop therapies for genetic heart diseases, called cardiomyopathies.
The two companies will make as much as $200 million on combined investment by 2018, Sanofi said.
-Write to Inti Landauro at inti.landauro@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
